Babylon hires exec to manage international growth and more digital health hires


Babylon announced Thursday the digital health firm had hired Andrew Hine as vice president of the go-to-market team for Asia, Europe, the Middle East and Africa.

The company said he’ll manage Babylon’s contracts and partnerships and work to increase its offerings and services in those regions. Hine joins Babylon from Ernst & Young, where he was head of health for the Middle East and North Africa. He’d previously worked at KPMG and the NHS, where he served as an NHS operational manager and trust board director.

“I have been fortunate to work at the frontline of healthcare delivery and within different health systems in various countries. These experiences have provided me with a profound understanding of the strengths and weaknesses of current healthcare delivery models around the world, the problems that need to be addressed and the potential for new care models, processes and technologies to dramatically improve the quality, accessibility and costs of care,” Hine said in a statement.

Babylon went public in 2021. The company reported revenue growth driven by its value-based care segment during the second quarter this year but also posted a $157.1 million loss. Last week, Babylon said its shareholders had approved a reverse share split aimed at preventing the company from being delisted from the New York Stock Exchange. Its shares had been selling for below $1.00 for more than 30 days.

Healthcare data analytics platform Komodo Health has appointed Lauren Stahl as vice president and head of sales.

Stahl has worked at Komodo for more than three years, most recently as vice president of healthcare sales. They’ve also served as head of customer success at Datavant and were founder and CEO of Sparkite, which focused on substance use disorder treatment.

“Lauren has demonstrated an exceptional track record of deepening customer relationships and unlocking new market and customer sales channels,” Dr. Aswin Chandrakantan, chief operating officer at Komodo Health, said in a statement. “As Komodo continues to invest in its end-to-end technology platform, having Lauren at the helm of our sales teams will only further accelerate our efforts to put Komodo’s best-in-class technology platform and patient-centric insights in the hands of organizations across life sciences, payers, government entities and more.”

Woebot Health, maker of a mental health chatbot, has named Brad Gescheider its chief commercial officer. 

Most recently, Gescheider served as global head of digital innovation and patient services for Sanofi’s immunology business. He’s also worked at Constant Therapy Health, GE Healthcare, McKesson and PatientsLikeMe.

“Brad’s understanding of the dynamics that shape today’s patient experience and his versatile background across a range of healthcare environments will be a major asset as we look to make mental health tools and digital therapeutics accessible to anyone who needs them,” Woebot CEO Michael Evers said in a statement. “As we expand and activate our strategic partnerships, Brad brings a great mix of compassion and experience at this pivotal moment in our development.”

Woebot has been building its leadership team this year. It recently hired a chief financial officer and a vice president of regulatory science and strategy.

Home diagnostics company Cue Health appointed Suzanne Stone as its chief commercial officer.

The company said Stone will lead Cue’s global commercial strategy and build sales and customer success teams. She previously worked as senior vice president of U.S. revenue at Dexcom

“Suzanne is a well-established commercial leader with extensive healthcare experience and an impressive track record of building great teams,” Ayub Khattak, chairman and CEO of Cue Health, said in a statement. “We look forward to accelerating our growth in our key customer categories and strengthening our position as a leading healthcare technology company by delivering a seamless and consistent brand experience under Suzanne’s capable leadership.”

Cue, best known for its at-home molecular COVID-19 test, also went public in 2021. The company plans to expand the number of tests compatible with its Cue Reader. Like a number of other digital health and health tech companies so far this year, Cue recently announced layoffs


Source link

Recommended Posts

No comment yet, add your voice below!

Add a Comment